Centene (CNC) Stock Forecast & Price Target

Centene
Bull Case

Here are some ways that investors could benefit from investing in Centene Co.:

• Centene Co. recently demonstrated strong financial performance by reporting an earnings per share of $2.51 for the quarter ended July 27, 2026, which significantly exceeded the analyst consensus estimate of $1.09, indicating a substantial beat that often signals improved operational efficiency and profitability to the market.
• The company's stock is currently trading at $64.49, which is below the average analyst price target of $70.05, suggesting that the stock may be undervalued relative to Wall Street's expectations for its future growth and earnings potential.
• Centene Co. is expanding its primary care access through a new partnership with Marathon Health, which will provide eligible members in Indiana and Missouri with $0 primary care visits, lab services, and virtual care beginning in 2027, potentially enhancing member retention and reducing long-term healthcare costs.
• The company has a favorable valuation profile with a price-to-earnings ratio of 12.52, which is relatively low for a healthcare provider, and analysts have noted that improving Medicaid margins and stronger Marketplace profitability support this valuation, making it an attractive option for value-oriented investors.
• Centene Co. has been narrowing its Medicare Advantage footprint to focus on dual eligibles, a strategic move that aims to improve plan economics and profitability by targeting a more stable and predictable membership segment, which could lead to better long-term financial performance.